|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Apr―15 |
Response to comment on “Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries” |
Andrew D. Mosholder, Michael Wernecke, David J. Graham |
2 |
[GO] |
2025―Feb―17 |
Comment on “Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries” |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam |
3 |
[GO] |
2024―Okt―19 |
Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries |
Andrew D. Mosholder, Hector S. Izurieta, Rongmei Zhang, Shanlai Shangguan, Yun Lu, Sandia Akhtar, et al. (+10) Michael Wernecke, Jiwei He, Yoganand Chillarige, Yuhui Feng, Armen Avagyan, Kira Leishear, Richard A. Forshee, Thomas E. MaCurdy, Jeffrey A. Kelman, David J. Graham |
4 |
[GO] |
2024―Jan―25 |
Combination eravacycline therapy for ventilator-associated pneumonia due to carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: A case series |
Melissa N. W. Jackson, Wenjing Wei, Norman S. Mang, Bonnie C. Prokesch, Jessica K. Ortwine |
5 |
[GO] |
2023―Aug―19 |
Baricitinib versus Tocilizumab in Critically Ill COVID-19 Patients: A Retrospective Cohort Study |
Grace M. Conroy, Seth R. Bauer, Andrea M. Pallotta, Abhijit Duggal, Lu Wang, Gretchen L. Sacha |
6 |
[GO] |
2021―Nov―24 |
The role of maternal COVID-19 vaccination in providing immunological protection to the newborn |
Sarah CJ Jorgensen, Lisa Burry, Najla Tabbara |
7 |
[GO] |
2021―Okt―24 |
Early clinical trial data and real-world assessment of COVID-19 vaccines: Insights from the Society of Infectious Diseases Pharmacists |
Nimish Patel, Jeannette Bouchard, Meredith B. Oliver, Melissa E. Badowski, Joseph J. Carreno |
8 |
[GO] |
2021―Okt―20 |
Corticosteroid use in ARDS and its Application to Evolving Therapeutics for Coronavirus Disease 2019 (COVID-19): A Systematic Review |
Kaitlin M Landolf, Steven M Lemieux, Christina Rose, Jackie P Johnston, Christopher D Adams, Jerry Altshuler, et al. (+12) Karen Berger, Deepali Dixit, Muhammad K Effendi, Mojdeh S Heavner, Diana Lemieux, Audrey J Littlefield, Andrea M Nei, Kent A Owusu, Marisa Rinehart, Blake Robbins, Ginger E Rouse, Melissa L Thompson Bastin |
9 |
[GO] |
2021―Sep―24 |
Beneficial and Harmful Outcomes of Tocilizumab in Severe COVID-19: A Systematic Review and Meta-Analysis |
Manuel Rubio-Rivas, Carlos G. Forero, Jose María Mora-Luján, Abelardo Montero, Francesc Formiga, Narcís A. Homs, et al. (+4) Joan Albà-Albalate, Laura Sánchez, Jordi Rello, Xavier Corbella |
10 |
[GO] |
2021―Jul―30 |
Bamlanivimab Use in Mild-to-Moderate COVID-19 Disease: A Matched Cohort Design |
Christopher J. Destache, Sarah J. Aurit, David Schmidt, Laura Peet Erkes, Maureen Tierney, Renuga Vivekanandan |
11 |
[GO] |
2021―Apr―09 |
Use of Remdesivir in Myasthenia Gravis and COVID-19 |
Bradley J Peters, Alejandro A Rabinstein, Hilary M DuBrock |
12 |
[GO] |
2020―Okt―17 |
Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID-19 COVID-19 |
Christopher D. Adams, Jerry Altshuler, Brooke L. Barlow, Deepali Dixit, Christopher A. Droege, Muhammad K. Effendi, et al. (+10) Mojdeh S. Heavner, Jackie P. Johnston, Amy L. Kiskaddon, Diana G. Lemieux, Steven M. Lemieux, Audrey J. Littlefield, Kent A Owusu, Ginger E. Rouse, Melissa L. Thompson Bastin, Karen Berger |
13 |
[GO] |
2020―Okt―12 |
Hydroxychloroquine in hospitalized COVID-19 patients: Real world experience assessing mortality |
Frank H. Annie, Cristian Sirbu, Keely R. Frazier, Mike Broce, B. Daniel Lucas |
14 |
[GO] |
2020―Okt―02 |
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19 |
Paul P. Dobesh, Toby C. Trujillo |
15 |
[GO] |
2020―Okt―02 |
Acetylcysteine for the Treatment of Suspected Remdesivir-Associated Acute Liver Failure in COVID-19: A Case Series |
Chancey Carothers, Kara Birrer, Mai Vo |
16 |
[GO] |
2020―Jul―09 |
COVID-19 Clinical Diagnostics and Testing Technology |
Cindy H. Chau, Jonathan D. Strope, William D. Figg |
17 |
[GO] |
2020―Jun―15 |
Baricitinib: A review of pharmacology, safety and emerging clinical experience in COVID-19 |
Sarah CJ Jorgensen, Christopher LY Tse, Lisa Burry, Linda D Dresser |
18 |
[GO] |
2020―Mai―23 |
Remdesivir: Review of pharmacology, pre-clinical data and emerging clinical experience for COVID-19 |
Sarah CJ Jorgensen, Razieh Kebriaei, Linda D Dresser |
19 |
[GO] |
2020―Mai―04 |
The Role of Scientific Publishing in the SARS-CoV-2 Pandemic |
C. Lindsay DeVane |
20 |
[GO] |
2020―Apr―27 |
Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression |
Kristen M. Johnson, Julie J. Belfer, Gina R. Peterson, Mark R. Boelkins, Lisa E. Dumkow |
21 |
[GO] |
2020―Apr―13 |
Delayed Initiation of Remdesivir in a COVID-19 Positive Patient |
Emily Hillaker, Julie J. Belfer, Anamaria Bondici, Hani Murad, Lisa E. Dumkow |
22 |
[GO] |
2020―Apr―08 |
Considerations for statin therapy in patients with COVID-19 |
Simin Dashti-Khavidaki, Hossein Khalili |
23 |
[GO] |
2020―Apr―08 |
Therapeutic Potential for Tetracyclines in the Treatment of COVID-19 |
Mohit Sodhi, Mahyar Etminan |
24 |
[GO] |
2020―Apr―08 |
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need |
Thomas P. Lodise, Michael J. Rybak |
25 |
[GO] |
2020―Apr―08 |
COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy |
Kathleen A. Stringer, Michael A Puskarich, Michael T. Kenes, Robert P. Dickson |
26 |
[GO] |
2020―Apr―07 |
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019 |
Ashley Barlow, Kaitlin M. Landolf, Brooke Barlow, Siu Yan Amy Yeung, Jason J. Heavner, Cassidy W. Claassen, Mojdeh S. Heavner |